Previous study believe that there is a correlation between 131I treatment and anaplastic transformation of thyroid cancer (8), the reason is that DNA damage of tumor patients is caused by 131I treatment, and the combination of p53 mutation and DNA damage induced by 131I treatment will lead to anaplastic transformation. This evidence concerns the gene TP53 and thyroid cancer.